Stockscreener 앱 받기
21.94
3.01%
-0.68
Alto Neuroscience Inc 주식(ANRO)의 최신 뉴스
Here's Why You Should Add ANRO Stock to Your Portfolio Now - Zacks Investment Research
At $2.32 a share, Alto Neuroscience (ANRO) CFO exercises options for 55,000 shares. - Stock Titan
Alto Neuroscience Insider Sold Shares Worth $3,567,247, According to a Recent SEC Filing - Moomoo
Alto Neuroscience(ANRO.US) Officer Sells US$3.57 Million in Common Stock - Moomoo
Form 4 Alto Neuroscience Inc For: 1 October By Investing.com - Investing.com South Africa
Form 4 Alto Neuroscience Inc For: 1 October By Investing.com - Investing.com Nigeria
Alto Neuroscience president and CFO Smith sells $3.57m in shares - Investing.com
Alto Neuroscience president and CFO Smith sells $3.57m in shares - Investing.com India
Exercising options at $2.35, Alto Neuroscience (ANRO)'s CFO sells shares. - Stock Titan
Alto Neuroscience President And CFO Sold Shares Worth Over $3.5M - TradingView
Stock options underpin an officer's proposed share sale at Alto Neuroscience (NYSE: ANRO). - Stock Titan
Alto Neuroscience, Inc.(NYSE: ANRO) added to S&P Global BMI Index - marketscreener.com
Alto Neuroscience Announces Participation in Upcoming September 2026 Investor Conferences - BioSpace
Alto Neuroscience announces September participation in investor conferences - Traders Union
Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire
Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Yahoo Finance
ANRO News | ALTO NEUROSCIENCE INC (NYSE:ANRO) - ChartMill
Alto Neuroscience Promotes Nick Smith to President and CFO - Contract Pharma
Alto Neuroscience Elevates Nicholas C. Smith to President and CFO with $6 Million Retention Deal - Kalkine Media
Nicholas C. Smith promoted to President and CFO at Alto Neuroscience - TradingView
Alto Neuroscience promotes Nick Smith to president and CFO By Investing.com - Investing.com India
Alto Neuroscience promotes Nick Smith to president and CFO By Investing.com - Investing.com Canada
Alto Neuroscience promotes Nick Smith to president and CFO By Investing.com - Investing.com UK
Alto Neuroscience, Inc. Promotes Nick Smith to President, Effective August 26, 2026 - marketscreener.com
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer - Yahoo Finance
Alto Neuroscience stock hits all-time high at 35.42 USD By Investing.com - Investing.com India
Alto Neuroscience stock hits all-time high at 35.42 USD - Investing.com
Alto Neuroscience stock hits all-time high at 35.42 USD By Investing.com - Investing.com UK
HC Wainwright Issues Optimistic Forecast for ANRO Earnings - MarketBeat
H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $55 - Moomoo
H.C. Wainwright raises Alto Neuroscience price target to $55 - Investing.com India
H.C. Wainwright raises Alto Neuroscience price target to $55 - Investing.com
H.C. Wainwright raises Alto Neuroscience price target to $55 By Investing.com - Investing.com Canada
H.C. Wainwright raises Alto Neuroscience price target to $55 - Investing.com
Alto Neuroscience (NYSE:ANRO) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
HC Wainwright Increases Alto Neuroscience (NYSE:ANRO) Price Target to $55.00 - MarketBeat
Is Alto Neuroscience (ANRO) Fully Valued As ALTO 207 Expands With New Funding? - Sahm
Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued? - Yahoo Finance
Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline? - Yahoo Finance
Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans - Yahoo Finance
Why Alto Neuroscience (ANRO) Is Up 13.5% After Expanding ALTO-207 Phase 3 And Securing New Funding - Sahm
Alto Neuroscience (ANRO) Slips 0.5% as Stock Holds Above Key $30.53 SupportFund Manager Survey - vinanet.vn
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC) - The Globe and Mail
Alto Neuroscience (ANRO) Slips 0.5% as Stock Holds Above Key $30.53 SupportCalendar Spread Trade - dars.gov.et
Alto Neuroscience (NYSE:ANRO) Upgraded to "Sell" at Wall Street Zen - MarketBeat
Alto Neuroscience (ANRO) investor group discloses 9.99% ownership cap - Stock Titan
Vestal Point Capital (ANRO) discloses 785,000-share Alto Neuroscience position in 13G/A - Stock Titan
BofA Securities Maintains Alto Neuroscience(ANRO.US) With Buy Rating - Moomoo
Why Alto Neuroscience (ANRO) Is Up 13.5% After Expanding ALTO-207 Phase 3 And Securing New Funding - simplywall.st
Alto Neuroscience (NYSE:ANRO) Stock Price Down 4.7%Here's Why - MarketBeat
2.71%
자본화:
|
볼륨(24시간):